For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Dexcom Inc (NASDAQ: DXCM) closed at $76.25 down -3.82% from its previous closing price of $79.28. In other words, the price has decreased by -$3.82 from its previous closing price. On the day, 6.54 million shares were traded. DXCM stock price reached its highest trading level at $80.215 during the session, while it also had its lowest trading level at $75.96.
Ratios:
For a deeper understanding of Dexcom Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.21 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.39. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.52. In the meantime, Its Debt-to-Equity ratio is 1.00 whereas as Long-Term Debt/Eq ratio is at 0.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on June 16, 2025, initiated with a Buy rating and assigned the stock a target price of $102.
On May 30, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $104.
On April 10, 2025, Mizuho started tracking the stock assigning a Outperform rating and target price of $85.Mizuho initiated its Outperform rating on April 10, 2025, with a $85 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 28 ’25 when Stern Sadie sold 1,466 shares for $88.99 per share. The transaction valued at 130,459 led to the insider holds 106,689 shares of the business.
SADIE STERN bought 1,466 shares of DXCM for $130,459 on Jul 28 ’25. On Jul 15 ’25, another insider, FOLETTA MARK G, who serves as the Director of the company, sold 2,750 shares for $85.17 each. As a result, the insider received 234,217 and left with 53,871 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DXCM now has a Market Capitalization of 29901819904 and an Enterprise Value of 29551839232. As of this moment, Dexcom’s Price-to-Earnings (P/E) ratio for their current fiscal year is 53.38, and their Forward P/E ratio for the next fiscal year is 29.44. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.19. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.95 while its Price-to-Book (P/B) ratio in mrq is 11.62. Its current Enterprise Value per Revenue stands at 6.871 whereas that against EBITDA is 32.007.
Stock Price History:
The Beta on a monthly basis for DXCM is 1.49, which has changed by 0.013289094 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, DXCM has reached a high of $93.25, while it has fallen to a 52-week low of $57.52. The 50-Day Moving Average of the stock is -9.78%, while the 200-Day Moving Average is calculated to be -3.73%.
Shares Statistics:
For the past three months, DXCM has traded an average of 3.57M shares per day and 3997890 over the past ten days. A total of 392.20M shares are outstanding, with a floating share count of 387.02M. Insiders hold about 1.31% of the company’s shares, while institutions hold 94.26% stake in the company. Shares short for DXCM as of 1752537600 were 8892579 with a Short Ratio of 2.49, compared to 1749772800 on 9375485. Therefore, it implies a Short% of Shares Outstanding of 8892579 and a Short% of Float of 2.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
